AstraZeneca Operating Income 2010-2024 | AZN

AstraZeneca operating income for the twelve months ending June 30, 2024 was $9.049B, a 23.2% increase year-over-year.

  • AstraZeneca annual operating income for 2023 was $8.193B, a 118.07% increase from 2022.
  • AstraZeneca annual operating income for 2022 was $3.757B, a 255.78% increase from 2021.
  • AstraZeneca annual operating income for 2021 was $1.056B, a 79.54% decline from 2020.

AstraZeneca Operating Income 2010-2024 | AZN

  • AstraZeneca annual operating income for 2023 was $8.193B, a 118.07% increase from 2022.
  • AstraZeneca annual operating income for 2022 was $3.757B, a 255.78% increase from 2021.
  • AstraZeneca annual operating income for 2021 was $1.056B, a 79.54% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$737B
Novo Nordisk (NVO)$472.8B
Johnson & Johnson (JNJ)$380.1B
AbbVie (ABBV)$355.5B
Merck (MRK)$255.1B
Novartis AG (NVS)$218.3B
Pfizer (PFE)$155B
Sanofi (SNY)$130.1B
Innoviva (INVA)$1.2B